Yahoo
LSE - Delayed Quote GBp

Spire Healthcare Group plc (SPI.L)

249.00 0.00 (0.00%)
As of 2:33:16 PM GMT. Market Open.

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
Name Title Pay Exercised Year Born
Sir David Morgan Sloman
Interim CEO & Vice Chairman of the Board 78.8k -- 1961
Mr. Harbant Singh Samra
CFO & Executive Director 445.9k -- 1979
Sir Ian Michael Cheshire M.A.
Advisor 245k -- 1959
Prof. Lisa Jane Grant
Group Chief Nursing Officer & COO -- -- 1976
Ms. Amie Gramlick
Director of Commercial Finance & Investor Relations -- -- --
Mr. Mantraraj Dipak Budhdev
Group General Counsel, Company Secretary & Chief People Officer -- -- 1986
Mr. Peter Corfield
Chief Commercial Officer -- -- --
Mr. Derrick Michael Farrell
Chief Executive Officer of Vita Health Group -- -- --
Dr. Catherine Mary Cale
Group Medical Director -- -- --
Ms. Rebecca Harper
Group Corporate Affairs Director -- -- --

Spire Healthcare Group plc

3 Dorset Rise
London, EC4Y 8EN
United Kingdom
44 20 7427 9000 https://www.spirehealthcare.com
Sector: 
Healthcare
Full Time Employees: 
17,800

Description

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Corporate Governance

Spire Healthcare Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

September 30, 2026 at 3:30 PM UTC

Spire Healthcare Group plc Earnings Date

Recent Events

May 21, 2026 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: